Cargando…

A single-sample mRNA molecular classification of bladder cancer predicting prognosis and response to immunotherapy

BACKGROUND: As an immunogenic cancer, crosstalk between cancer cells and immune cells has been gradually recognized in bladder cancer (BC). Several studies have emphasized the clinical significance of the molecular stratification of BC without highlighting the role of the immune microenvironment. Al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Kun, He, Mingjing, Chen, Bo, Zhou, Xianghong, Zhang, Chichen, Zhang, Zilong, Hu, Dan, Jiang, Zhongyuan, Wei, Qiang, Qiu, Shi, Yang, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360513/ https://www.ncbi.nlm.nih.gov/pubmed/35958899 http://dx.doi.org/10.21037/tau-21-887

Ejemplares similares

DOK3 promotes proliferation and inhibits apoptosis of prostate cancer via the NF-κB signaling pathway
por: Jin, Kun, et al.
Publicado: (2023)

Blockade of integrin signaling reduces chemotherapy-induced premature senescence in collagen cultured bladder cancer cells
por: Deng, Linghui, et al.
Publicado: (2022)

Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
por: Zhou, Xianghong, et al.
Publicado: (2020)

Urinary polycyclic aromatic hydrocarbon metabolites are positively related to serum testosterone levels of males and serum estradiol levels of females among U.S. adults
por: Yuan, Qiming, et al.
Publicado: (2022)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy
por: Wang, Zhifeng, et al.
Publicado: (2022)

The association between sex hormones and periodontitis among American adults: A cross-sectional study
por: Su, Xingyang, et al.
Publicado: (2023)

Sleep duration and testosterone levels in community older men: results from the West China Health and Aging Trend study
por: Zhou, Xianghong, et al.
Publicado: (2023)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

Identification of a 13-mRNA signature for predicting disease progression and prognosis in patients with bladder cancer
por: Yin, Hubin, et al.
Publicado: (2020)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients
por: Cui, Zhongyuan, et al.
Publicado: (2021)

Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
por: Duan, Li-Juan, et al.
Publicado: (2022)

mRNA therapeutics in cancer immunotherapy
por: Beck, Jan D., et al.
Publicado: (2021)

mRNA vaccines for cancer immunotherapy
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2022)

mRNA delivery in cancer immunotherapy
por: Zhong, Yichen, et al.
Publicado: (2023)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Complete androgen blockade vs. medical castration alone as adjuvant androgen deprivation therapy for prostate cancer patients following radical prostatectomy: a retrospective cohort study
por: Jin, Di, et al.
Publicado: (2022)

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
por: Zhang, Hongxian, et al.
Publicado: (2021)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
por: Cao, Rui, et al.
Publicado: (2021)

A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer
por: Zhang, Chen, et al.
Publicado: (2020)

m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma
por: Huang, Zhen-Dong, et al.
Publicado: (2022)

Assessment of PD-L1 mRNA expression in gastrointestinal tumors and the response to immunotherapy
por: Qiu, Qingqing, et al.
Publicado: (2022)

mRNA as novel technology for passive immunotherapy
por: Schlake, Thomas, et al.
Publicado: (2018)

A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA
por: Zhang, Xiaoxue, et al.
Publicado: (2022)

Associations between urinary concentrations of bisphenols and serum concentrations of sex hormones among US. Males
por: Zhang, Chichen, et al.
Publicado: (2022)

Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy
por: Ren, Xiufang, et al.
Publicado: (2022)

Association between Dietary Inflammatory Index and serum Klotho concentration among adults in the United States
por: Zhang, Chichen, et al.
Publicado: (2022)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
por: Deal, Cailin E., et al.
Publicado: (2021)

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
por: Meng, Jialin, et al.
Publicado: (2021)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Prognostic value of CLIC3 mRNA overexpression in bladder cancer
por: Chen, Mei, et al.
Publicado: (2020)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy
por: Shi, Yanlong, et al.
Publicado: (2023)

Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer
por: Huang, Yuquan, et al.
Publicado: (2023)

Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis
por: Li, Jianpeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ksncd4vg2qsja5uukhbdrql7th